Associated Papers
Genomic determinants of response and resistance to pirtobrutinib in relapsed/refractory chronic lymphocytic leukemia.
Brown JR et al.
Blood, 2026
41055698 (PubMed )
Supplement: BLOOD_BLD-2024-027009-mmc5.xlsx › Sheet_1
CYP2D6 genotype in relation to hot flashes as tamoxifen side effect in a Dutch cohort of the tamoxifen exemestane adjuvant multinational (TEAM) trial.
Dezentjé VO et al.
Breast Cancer Research and Treatment, 2014
Estrogen receptor inducibility of the human Na+/H+ exchanger regulatory factor/ezrin-radixin-moesin binding protein 50 (NHE-RF/EBP50) gene involving multiple half-estrogen response elements.
Ediger TR et al.
Molecular Endocrinology (baltimore, Md.), 2002
A transcriptionally active estrogen receptor mutant is a novel type of dominant negative inhibitor of estrogen action.
McInerney EM et al.
Molecular Endocrinology (baltimore, Md.), 1996
Analysis of mechanisms that determine dominant negative estrogen receptor effectiveness.
Schodin DJ et al.
The Journal of Biological Chemistry, 1995
Select a paper to view details